Insider Selling: Medidata Solutions (MDSO) CFO Sells 3,000 Shares of Stock

Medidata Solutions (NASDAQ:MDSO) CFO Rouven Bergmann sold 3,000 shares of the firm’s stock in a transaction dated Monday, May 21st. The shares were sold at an average price of $75.52, for a total value of $226,560.00. Following the transaction, the chief financial officer now owns 84,642 shares in the company, valued at $6,392,163.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Rouven Bergmann also recently made the following trade(s):

  • On Thursday, April 19th, Rouven Bergmann sold 4,000 shares of Medidata Solutions stock. The shares were sold at an average price of $71.50, for a total value of $286,000.00.
  • On Monday, March 19th, Rouven Bergmann sold 2,000 shares of Medidata Solutions stock. The shares were sold at an average price of $66.30, for a total value of $132,600.00.

Shares of Medidata Solutions stock traded up $0.64 during trading on Wednesday, reaching $76.17. The company’s stock had a trading volume of 579,200 shares, compared to its average volume of 625,604. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.63 and a current ratio of 1.63. The firm has a market capitalization of $4.50 billion, a PE ratio of 89.61, a PEG ratio of 3.81 and a beta of 1.49. Medidata Solutions has a one year low of $59.60 and a one year high of $85.92.

Medidata Solutions (NASDAQ:MDSO) last posted its quarterly earnings data on Thursday, April 19th. The company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.05. The business had revenue of $149.20 million for the quarter, compared to analyst estimates of $146.73 million. Medidata Solutions had a return on equity of 11.36% and a net margin of 7.96%. The firm’s revenue for the quarter was up 16.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.31 earnings per share. research analysts forecast that Medidata Solutions will post 0.98 earnings per share for the current year.

Hedge funds have recently added to or reduced their stakes in the stock. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Medidata Solutions by 48.3% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,242 shares of the company’s stock worth $205,000 after buying an additional 1,056 shares in the last quarter. Meadow Creek Investment Management LLC grew its position in Medidata Solutions by 31.4% during the fourth quarter. Meadow Creek Investment Management LLC now owns 3,680 shares of the company’s stock worth $233,000 after buying an additional 880 shares in the last quarter. Asset Management One Co. Ltd. grew its position in Medidata Solutions by 102.7% during the first quarter. Asset Management One Co. Ltd. now owns 3,948 shares of the company’s stock worth $248,000 after buying an additional 2,000 shares in the last quarter. Polen Capital Management LLC grew its position in Medidata Solutions by 77.0% during the fourth quarter. Polen Capital Management LLC now owns 4,640 shares of the company’s stock worth $294,000 after buying an additional 2,018 shares in the last quarter. Finally, Joel Isaacson & Co. LLC acquired a new stake in Medidata Solutions during the first quarter worth about $314,000.

Several equities analysts have weighed in on MDSO shares. TheStreet upgraded Medidata Solutions from a “c+” rating to a “b-” rating in a report on Monday, March 12th. Zacks Investment Research upgraded Medidata Solutions from a “hold” rating to a “buy” rating and set a $70.00 target price on the stock in a report on Wednesday, February 14th. Needham & Company LLC cut their target price on Medidata Solutions to $75.00 and set a “buy” rating on the stock in a report on Friday, February 9th. BidaskClub upgraded Medidata Solutions from a “hold” rating to a “buy” rating in a report on Friday, May 4th. Finally, Dougherty & Co restated a “buy” rating and set a $89.00 target price (up from $79.00) on shares of Medidata Solutions in a report on Thursday, May 10th. Five investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $84.50.

About Medidata Solutions

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.

Insider Buying and Selling by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit